Skip to content

Edwards Lifesciences Corp

EW

CIK 0001099800

← back to feed
Revenue (TTM)
$6.15B
+337.8% YoY Q1 Apr 2026
Net Income (TTM)
$1.36B
+178.4% YoY Q1 Apr 2026
EPS Diluted (TTM)
$2.33
+181.5% YoY Q1 Apr 2026
Gross Margin
78.0%
Q1 Apr 2026
Operating Margin
25.9%
Q1 Apr 2026
Net Margin
22.2%
Q1 Apr 2026
Free Cash Flow (TTM)
$337.1M
Q1 Apr 2026
Cash
$2.45B
Q1 Apr 2026
Total Debt
$598.5M
Q1 Apr 2026
Shares Outstanding
575.8M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings